Adjuvant Pembrolizumab in Patients with Clear Cell Renal Cell Carcinoma: From Eligibility to Individual Treatment Decision

European Urology Oncology · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles